TNFRSF12A/CD266 Recombinant Antibody

$25 ug total protein per lane of various lysates (see on figure) probed with TNFRSF12A\/CD266 monoclonal antibody, unconjugated (bsm-52646R) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at r.t. for 60 min.$

25 ug total protein per lane of various lysates (see on figure) probed with TNFRSF12A\/CD266 monoclonal antibody, unconjugated (bsm-52646R) at 1:1000 dilution and 4\u00b0C overnight incubation. Followed by conjugated secondary antibody incubation at r.t. for 60 min.

Applications

Reactivity

Human
Mouse

Predicted Reactivity

Overview
Catalog #	bsm-52646r
Product Name	TNFRSF12A/CD266 Recombinant Antibody
Applications	WB
Reactivity	Human, Mouse
Predicted Reactivity	Rat
Specifications
Conjugation	Unconjugated
Host	Rabbit
Source	C terminal Human TWEAKR
Clonality	Recombinant
Isotype	IgG
Concentration	Lot dependent
Purification	Purified by Protein A.
Storage Buffer	0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol
Storage Condition	Store at -20°C for 12 months.
Target
Gene ID	51330
Swiss Prot	Q9NP84
Synonyms	Tumor necrosis factor receptor superfamily member 12A, Fibroblast growth factor-inducible immediate-early response protein 14, Tweak-receptor, CD_antigen: CD266, FGF-inducible 14, TweakR, TNFRSF12A
Background	Receptor for TNFSF12/TWEAK. Weak inducer of apoptosis in some cell types. Promotes angiogenesis and the proliferation of endothelial cells. May modulate cellular adhesion to matrix proteins.
Application Dilution
WB	1:300-5000